Merck & Co., Inc. SG&A Expense 2007-2026 | MRK
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is Merck & Co., Inc.'s current sg&a expense?
Merck & Co., Inc. (MRK) annual sg&a expense for 2025 was $10.73B, a 0.77% decline from 2024. Merck & Co., Inc. sg&a expense for the quarter ending March 31, 2026 was $2.70B.
What was Merck & Co., Inc.'s sg&a expense in 2024?
Merck & Co., Inc. annual sg&a expense for 2024 was $10.82B, a 2.97% increase from 2023.
What was Merck & Co., Inc.'s sg&a expense in 2023?
Merck & Co., Inc. annual sg&a expense for 2023 was $10.50B, a 4.60% increase from 2022.
What is Merck & Co., Inc.'s 5-year sg&a expense CAGR?
Merck & Co., Inc. sg&a expense grew at a compound annual growth rate (CAGR) of 3.69% from FY2020 to FY2025, going from $8.96B to $10.73B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.7%
FY2020
$8.96B
→
FY2025
$10.73B
07080910111213141516171819202122232425
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $10.73B | -0.8% | 10-K |
| FY2024 | $10.82B | +3.0% | 10-K |
| FY2023 | $10.50B | +4.6% | 10-K |
| FY2022 | $10.04B | +4.2% | 10-K |
| FY2021 | $9.63B | +7.6% | 10-K |
| FY2020 | $8.96B | -5.3% | 10-K |
| FY2019 | $9.46B | -6.4% | 10-K |
| FY2018 | $10.10B | +0.3% | 10-K |
| FY2017 | $10.07B | +0.6% | 10-K |
| FY2016 | $10.02B | -2.9% | 10-K |
| FY2015 | $10.31B | -11.1% | 10-K |
| FY2014 | $11.61B | -2.6% | 10-K |
| FY2013 | $11.91B | -6.8% | 10-K |
| FY2012 | $12.78B | -7.0% | 10-K |
| FY2011 | $13.73B | +4.6% | 10-K |
| FY2010 | $13.13B | +53.6% | 10-K |
| FY2009 | $8.54B | +15.8% | 10-K |
| FY2008 | $7.38B | -2.4% | 10-K |
| FY2007 | $7.56B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →